PEMF for
AC Joint Pain.

July 2026 · 8 min read · Sports Medicine Protocol

What Is Acromioclavicular Joint Pain?

The acromioclavicular (AC) joint is located at the top of the shoulder where the acromion of the scapula meets the lateral end of the clavicle. It is stabilized by two ligament systems: the acromioclavicular ligaments (horizontal stability) and the coracoclavicular ligaments — the conoid and trapezoid ligaments (vertical stability). AC joint injuries range from mild sprains to complete dislocations, with each grade requiring a different clinical approach.

AC joint pain presents as point tenderness at the shoulder's apex, pain with horizontal adduction (cross-body reach), and a characteristic "step deformity" visible in higher-grade injuries. It is one of the most common shoulder injuries in contact sports and falls — accounting for 40–50% of all shoulder injuries in physically active populations.

The Philippine Sports Injury Burden

The Philippines has a uniquely high prevalence of AC joint injuries driven by sport and infrastructure:

• Basketball: An estimated 30 million active basketball players nationwide — the highest per-capita participation rate in Southeast Asia. AC joint separation is endemic in this population from collisions and falls on an outstretched arm.
• Volleyball & combat sports: Including boxing, mixed martial arts, and wrestling — all high-incidence sports for shoulder separation.
• Motorcycle collisions: With 7.3 million registered motorcycles, AC joint injuries from falls are among the most common trauma presentations at Philippine emergency departments.
• Occupational falls: Construction workers (3 million+) and agricultural workers with frequent falls represent a non-sport segment with high AC injury incidence.

Injury Classification: Who Benefits from PEMF?

The Rockwood classification is the standard for AC joint injury grading:

The majority of AC joint injuries presenting to Philippine sports medicine clinics are Grade I–III — precisely the population where PEMF provides its greatest non-invasive benefit.

How PEMF Works on AC Joint Injuries

Four cellular mechanisms underlie PEMF's efficacy in AC joint pathology:

1. Ligament collagen remodeling: PEMF upregulates TGF-β1 and VEGF, accelerating fibroblast proliferation and organized collagen fiber deposition in torn acromioclavicular and coracoclavicular ligaments (PubMed 19371845; Frontiers in Sports & Active Living 2026, doi:10.3389/fspor.2026.1694944).
2. Anti-inflammatory cascade suppression: NF-κB inhibition reduces IL-1β and TNF-α concentrations in the joint capsule, resolving the acute and subacute inflammatory phase faster than the natural timeline.
3. Periarticular microcirculation enhancement: eNOS upregulation improves blood flow to the hypovascular ligamentous tissue — a critical bottleneck in ligament healing given its inherently poor vascularity.
4. Analgesic effect via A-δ and C fiber threshold modulation: Raises the firing threshold of nociceptors in the joint capsule, providing immediate pain relief that enables earlier range-of-motion rehabilitation.

The Clinical Evidence

AC joint–specific PEMF RCTs are not yet published as a standalone condition; the evidence base derives from the shoulder region broadly and soft-tissue injury categories:

• PMC12088032 (PLoS ONE May 2025 meta-analysis, shoulder PEMF): Pain VAS reduced by 2.6 points (95% CI: 1.8–3.4); DASH functional score improved from 45.2 to 21.8; function SMD = 1.14 (large effect); ROM significantly improved across flexion, abduction, and internal rotation.
• PMC11914662 (multicenter RCT, n=91, joint & soft-tissue pain): 36% pain reduction vs. 10% standard care (p<0.0001); 55% medication reduction vs. 12% control.
• PMC12916110 (Frontiers Sports 2026 systematic review, PEMF for soft-tissue injuries): Confirms accelerated return-to-sport timelines and reduced re-injury rates across ligamentous injury categories.
• PubMed 19371845 (Strauch 2009 soft-tissue mechanism review): VEGF upregulation, collagen fiber alignment, and fibroblast stimulation confirmed as primary structural repair pathways.

Honest framing: AC joint–specific RCTs are not yet available. Evidence is extrapolated from directly analogous shoulder soft-tissue conditions and general ligament repair data. PEMF is positioned as an adjunct to physiotherapy and graded return-to-sport protocols — not a standalone treatment.

Clinical Protocol — AC Joint PEMF

Coil placement: directly over the AC joint (superior shoulder) with supplementary paravertebral placement at C4–C6 for central analgesic effect. Grade II–III injuries with significant edema: begin with anti-inflammatory phase only for the first 4 sessions before advancing to repair frequencies. Total course: 16–20 sessions over 6–8 weeks; Grade I injuries may complete in 10–12 sessions.

PEMF vs. Standard AC Joint Treatments

Who Is the Ideal Patient?

PEMF is indicated for AC joint pain in:

• Grade I–III AC separations (acute phase to subacute, ≥48 hours post-injury)
• Chronic AC joint degeneration (OA of the AC joint — distinct from acute injury)
• Post-surgical patients with Grade IV–VI repair, after removal of Kirschner wire fixation
• Athletes requiring accelerated return-to-sport timelines
• Patients with NSAID intolerance or steroid injection failure

Contraindications: cardiac pacemaker or neurostimulator; active metallic fixation hardware in the AC joint (Grade IV–VI surgical repair still in situ); active local infection; acute soft-tissue hematoma requiring evacuation.

Revenue Model for Philippine Clinics

AC joint injuries represent a high-compliance, course-completing patient segment — athletes are motivated and have clear functional return-to-sport goals:

• Grade I–II: 10–12 sessions × ₱1,500–₱2,500 = ₱15,000–₱30,000 per patient
• Grade III: 16–20 sessions × ₱1,500–₱2,500 = ₱24,000–₱50,000 per patient
• Chronic AC OA: ongoing maintenance 2–4×/month = ₱6,000–₱15,000/month recurring
• Sports team contracts: basketball, volleyball, and combat sports teams as B2B clients — 5–15 athletes per team × ₱20,000–₱40,000 per season = ₱100,000–₱600,000/team/year

In 70+ Israeli clinics (population: 9M) — now expanding to the Philippines — AC joint and shoulder injuries represent approximately 15–20% of total PEMF case volume, making it one of the five highest-volume indication categories.

Frequently Asked Questions

When can the athlete return to sport after AC joint PEMF?

Grade I injuries: typically 1–2 weeks with concurrent PEMF; Grade II: 3–6 weeks with full PEMF course; Grade III: 6–12 weeks depending on conservative vs. surgical management. PEMF's primary value is reducing the acute inflammatory phase and accelerating the collagen repair window — each PEMF session is designed to support the timeline, not replace functional rehabilitation.

Can PEMF prevent the need for surgery in Grade III injuries?

Grade III injuries are managed conservatively as first-line in most international guidelines, with surgery reserved for refractory cases. PEMF supports the conservative pathway by optimizing ligament healing conditions — some Grade III patients treated conservatively with PEMF experience functional outcomes equivalent to surgical repair. No comparative RCT exists for this specific question; the decision remains with the treating orthopedic surgeon.